Range of Motion of Standard and High-Flexion Posterior Cruciate Retaining Total Knee Prostheses
Study Details
Study Description
Brief Summary
The purpose of this prospective, randomized study was to compare pain, functional outcome and ranges of motion of the knees in patients receiving either a standard posterior cruciate-retaining or a high-flexion posterior cruciate-retaining total knee prosthesis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Detailed Description
The main goals of total knee arthroplasty are pain relief and improvement of function and range of motion. The purpose of this study was to compare ranges of motion of the knees in patients receiving either a standard posterior crucaite-retaining or a high-flexion posterior cruciate-retaining total knee prosthesis.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: NexGen CR knee prosthesis side of knee operated with total knee replacement with Nexgen CR prosthesis |
Device: Total knee replacement with NexGen CR knee prosthesis
comparison of functional outcome in patients receiving either NexGen posterior cruciate-retaining or a high-flexion posterior cruciate-retaining total knee prosthesis
Other Names:
|
Active Comparator: NexGen CR-Flex knee prosthesis side of knee operated with total knee arthroplasty using Nexgen CR-flex prosthesis |
Device: Total knee replacement(TKR) with Nexgen CR-flex
TKR using Nexgen CR-flex implant
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Change in Knee Society Knee Score [baseline and 3 years]
change in knee score will be compared with baseline and follow up of 3 years. The knee society knee score range from 0 to 100 points, 100 being the best possible outcome. Baseline-NexGen (CR) knee socre:29 points Baseline-NexGen (CR-Flex) knee socre:29 points Follow up of 3 years-NexGen (CR) knee socre: 93.7 points Follow up of 3 years-NexGen (CR-Flex) knee socre: 93.9 points
Eligibility Criteria
Criteria
Inclusion Criteria:
- osteoarthritis that was severe enough to warrant total knee arthroplasty after an adequate trial of nonoperative therapy, and the need for bilateral total knee arthroplasties
Exclusion Criteria:
-
inflammatory arthritis
-
osteoarthritis of the hip causing pain or restricted mobility
-
a foot or ankle disorder which limited walking
-
dementia or a neurological disorder including a past history of stroke which affected mobility
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Ewha Womans University
Investigators
- Study Director: Young-Hoo Kim, MD, Ewha Womans University Mokdong Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2007-7
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | NexGen CR and CR-flex Knee Prosthesis |
---|---|
Arm/Group Description | The NexGen posterior cruciate-retaining total knee arthroplasty prosthesis (NexGen CR Prosthesis; Zimmer)) on one side and The NexGen posterior cruciate-retaining flex total knee arthroplasty prosthesis (NexGen CR-Flex; Zimmer) on the other side |
Period Title: Overall Study | |
STARTED | 54 |
COMPLETED | 54 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | NexGen CR and CR-flex Knee Prosthesis |
---|---|
Arm/Group Description | The NexGen posterior cruciate-retaining total knee arthroplasty prosthesis (NexGen CR Prosthesis; Zimmer)) on one side and The NexGen posterior cruciate-retaining flex total knee arthroplasty prosthesis (NexGen CR-Flex; Zimmer) on the other side |
Overall Participants | 54 |
Age (Count of Participants) | |
<=18 years |
0
0%
|
Between 18 and 65 years |
11
20.4%
|
>=65 years |
43
79.6%
|
Age (years) [Mean (Standard Deviation) ] | |
Mean (Standard Deviation) [years] |
69.7
(6.43)
|
Sex: Female, Male (Count of Participants) | |
Female |
49
90.7%
|
Male |
5
9.3%
|
Region of Enrollment (participants) [Number] | |
Korea, Republic of |
54
100%
|
Outcome Measures
Title | Change in Knee Society Knee Score |
---|---|
Description | change in knee score will be compared with baseline and follow up of 3 years. The knee society knee score range from 0 to 100 points, 100 being the best possible outcome. Baseline-NexGen (CR) knee socre:29 points Baseline-NexGen (CR-Flex) knee socre:29 points Follow up of 3 years-NexGen (CR) knee socre: 93.7 points Follow up of 3 years-NexGen (CR-Flex) knee socre: 93.9 points |
Time Frame | baseline and 3 years |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | High-Flexion Posterior Cruciate Retaining TKA | High-Flexion Posterior Cruciate Scrificing TKA |
---|---|---|
Arm/Group Description | ||
Measure Participants | 54 | 54 |
Mean (Standard Deviation) [scores on a scale] |
93.9
(4.66)
|
93.7
(4.53)
|
Adverse Events
Time Frame | ||
---|---|---|
Adverse Event Reporting Description | ||
Arm/Group Title | NexGen CR and CR-flex Knee Prosthesis | |
Arm/Group Description | The NexGen posterior cruciate-retaining total knee arthroplasty prosthesis (NexGen CR Prosthesis; Zimmer)) on one side and The NexGen posterior cruciate-retaining flex total knee arthroplasty prosthesis (NexGen CR-Flex; Zimmer) on the other side | |
All Cause Mortality |
||
NexGen CR and CR-flex Knee Prosthesis | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
NexGen CR and CR-flex Knee Prosthesis | ||
Affected / at Risk (%) | # Events | |
Total | 0/54 (0%) | |
Other (Not Including Serious) Adverse Events |
||
NexGen CR and CR-flex Knee Prosthesis | ||
Affected / at Risk (%) | # Events | |
Total | 0/54 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Young-Hoo Kim, MD |
---|---|
Organization | Ewha Womans University School of Medicine |
Phone | 822-26505900 |
younghookim@ewha.ac.kr |
- 2007-7